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Abstract
Background Bile acids (BAs) regulate cells by acti-
vating nuclear and membrane-bound receptors.
G protein coupled bile acid receptor 1 (GpBAR1) is a
membrane-bound G-protein-coupled receptor that can
mediate the rapid, transcription-independent actions
of BAs. Although BAs have well-known actions on
motility and secretion, nothing is known about the
localization and function of GpBAR1 in the gastroin-
testinal tract. Methods We generated an antibody to
the C-terminus of human GpBAR1, and characterized
the antibody by immunofluorescence and Western
blotting of HEK293-GpBAR1-GFP cells. We localized
GpBAR1 immunoreactivity (IR) and mRNA in the
mouse intestine, and determined the mechanism by
which BAs activate GpBAR1 to regulate intestinal
motility. Key Results The GpBAR1 antibody specifi-
cally detected GpBAR1-GFP at the plasma membrane
of HEK293 cells, and interacted with proteins corre-
sponding in mass to the GpBAR1-GFP fusion protein.
GpBAR1-IR and mRNA were detected in enteric gan-
glia of the mouse stomach and small and large intes-
tine, and in the muscularis externa and mucosa of the
small intestine. Within the myenteric plexus of the
intestine, GpBAR1-IR was localized to 50% of all
neurons and to >80% of inhibitory motor neurons and
descending interneurons expressing nitric oxide syn-
thase. Deoxycholic acid, a GpBAR1 agonist, caused a
rapid and sustained inhibition of spontaneous phasic
activity of isolated segments of ileum and colon by a
neurogenic, cholinergic and nitrergic mechanism, and
delayed gastrointestinal transit. Conclusions &
Inferences G protein coupled bile acid receptor 1 is
unexpectedly expressed in enteric neurons. Bile acids
activate GpBAR1 on inhibitory motor neurons to re-
lease nitric oxide and suppress motility, revealing a
novel mechanism for the actions of BAs on intestinal
motility.
Keywords bile acids, enteric neurons, G protein-
coupled receptor, motility.
INTRODUCTION
Bile acids (BAs) are essential for the normal digestion
and absorption of lipids and vitamins.1 Chenodeoxy-
cholic acid (CDCA) and cholic acid (CA), the two
primary BAs in humans, are secreted from the gall-
bladder into the intestine, and are absorbed and
recycled via the enterohepatic circulation. The small
amounts of primary BAs that reach the colon are dehy-
droxylated by bacterial enzymes, forming secondary
BAs [e.g. lithocholic acid (LCA), deoxycholic acid
(DCA), taurolithocholic acid (TLCA), ursodeoxycholic
acid (UDCA)]. Cholestasis, which is characterized by
impaired bile flow into the intestine, is a common
feature of acute and chronic liver diseases. The toxic
accumulation of BAs in the circulation leads to
profound systemic metabolic disturbances by mecha-
nisms that are not fully understood.1
In addition to their role in digestion, BAs have
direct receptor-mediated effects on multiple pro-
cesses.2,3 Nuclear receptors mediate the delayed
actions of BAs that require transcription. Bile acids
activate the farnesoid X receptor (FXR or NR1H4), a
nuclear receptor that regulates the expression of
biosynthetic enzymes and binding proteins for
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BAs.4,5 Bile acids can activate other nuclear receptors,
including the pregnane X receptor (PXR),6 and the
vitamin D receptor,7 which protect against the toxic
effects of BAs. Bile acids also rapidly activate signal-
ing pathways and cellular functions that do not
require transcription, including cAMP generation,
calcium mobilization and activation of protein kinase
C and mitogen-activated protein kinases.8–11 G pro-
tein coupled bile acid receptor 1 (GpBAR1, also
known as TGR5 or M-BAR1) is a membrane-bound
G protein-coupled receptor for BAs.12,13 Primary and
secondary BAs activate GpBAR1, which couples to
adenylyl cyclase and cAMP generation. G protein
coupled bile acid receptor 1 is ubiquitous, with the
highest expression in brown adipose tissue, placenta,
spleen macrophages/monocytes, Kupffer cells, gall-
bladder, and intestine.12–16 Emerging evidence indi-
cates that GpBAR1 controls weight gain and energy
expenditure in brown adipose tissue and skeletal
muscle by promoting the processing of thyroid hor-
mone,17,18 regulates hepatic microcirculation,16 and
chloride secretion in the gall bladder,14 suppresses
cytokine release from macrophages,13 and stimu-
lates secretion of glucagon-like peptide.19 However,
nothing is known about the localization and function
of GpBAR1 in the intestine.
The intestine is exposed to high concentrations of
BAs, and BAs have well-described effects on intestinal
motility and secretion. Bile acids stimulate fluid,
electrolyte and mucus secretion in the intestine, which
may protect against their toxic actions.20–22 Bile acids
also affect intestinal motility, although whether their
actions are stimulatory or inhibitory is controversial.
In vivo studies report that BAs either stimulate
motility or have no effect.23–25 Infusion of BAs into
the human intestine delays transit, supporting an
inhibitory role.26–28 In vitro studies show that BAs
inhibit contractions of rabbit and guinea pig intes-
tine.29,30 However, the mechanisms by which BAs
regulate intestinal function are unknown.
We examined the location and function of GpBAR1
in the mouse gastrointestinal tract. Using a thoroughly
characterized GpBAR1 antibody, we made the unex-
pected observation that GpBAR1 immunoreactivity
(IR) is prominently expressed by myenteric inhibitory
motor neurons of the intestine. We examined the
effects of GpBAR1 agonists on intestinal motility and
transit, and determined that BAs inhibit motility by a
mechanism that is consistent with activation of
GpBAR1 on inhibitory motor neurons that release
nitric oxide (NO). We have thereby identified a novel
mechanism for the well-known effects of BAs on
intestinal motility.
MATERIALS AND METHODS
Animals
Male mice (C57/BL6, 20–25 g, Charles River, Hollister, CA, USA)
were killed by sodium pentobarbital injection (200 mg kg)1, i.p.)
and bilateral thoracotomy. The Institutional Animal Care and Use
Committee approved all procedures.
Antibodies
New Zealand White rabbits were immunized with a peptide
corresponding to the C-terminus of human GpBAR1 with an
N-terminal Cys residue for conjugation to keyhole limpet
hemocyanin (Cys-P310GPSIAYHPSSQSSVDLDLN330) (Pacific
Immunology, San Diego, CA, USA). Rabbits were immunized
with 200 lg of conjugated peptide in complete Freunds adjuvant,
and were subsequently immunized after each blood collection
(2–3 weeks) with 100 lg conjugated peptide in incomplete Fre-
unds adjuvant. Antibody generation was monitored by ELISA
using the immunizing peptide. Antibody collected after the fourth
and final blood collection was purified by affinity chromatogra-
phy. Antibody P87/88 was used throughout. Table 1 shows
sources and dilutions of other primary antibodies.
Generation of GpBAR1 constructs
Total RNA from human duodenum (5 lg) was reverse tran-
scribed. Primers were designed corresponding to human
GpBAR1 (forward 5¢-taaaagcttatgacgcccaacagcactggc-3¢; reverse
Table 1 Sources and dilutions of primary
antibodies Antigen Species Conditions Source
GpBAR1 Rabbit IF/WB, 1 : 100
ChAT Goat IF, 1 : 200 Millipore, Temecula, CA, USA
GFAP Goat IF, 1 : 400 NOVUS Biologicals, Littleton, CO, USA
GFP Mouse IF/WB, 1 : 10 000 Santa Cruz Biotechnology, Santa Cruz, CA, USA
NFM Chicken IF, 1 : 500 Gene Tex Inc., Irvine, CA, USA
NOS Goat IF, 1 : 500 NOVUS Biologicals, Littleton, CO, USA
PGP9.5 Chicken IF, 1 : 500 Abcam Inc., Cambridge, MA, USA
ChAT, choline acetyltransferase; GFAP, glial fibrillary acidic protein; GFP, green fluorescent
protein; GpBAR1, G protein coupled bile acid receptor 1; NFM, neurofilament M; NOS, nitric
oxide synthase; IF, immunofluorescence; WB, Western blot.
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5¢-ttactcgagttagttcaagtccaggtcgac-3¢). A construct with green fluo-
rescent protein (GFP) fused to the C-terminus of human GpBAR1
(GpBAR1-GFP) was generated by subcloning into pEGFP-N1
(Clontech, Mountain View, CA, USA). Constructs were con-
firmed by sequencing.
Generation and maintenance of cell lines
Human embryonic kidney (HEK293) cells were cultured in
Dulbeccos modified Eagles medium supplemented with 10%
heat-inactivated fetal bovine serum and zeocin or hygromycin B
(100 lg mL)1). Cells stably expressing human GpBAR1-GFP
(HEK-GpBAR1-GFP cells) were generated with the Flp-In
system (Invitrogen, Carlsbad, CA, USA). In some experiments,
cells were transiently transfected with GpBAR1-GFP or empty
vector (vector control, VC) using Lipofectamine 2000 (Invitro-
gen), and were studied after 48 h.
cAMP generation
Cells were grown to confluency and treated with forskolin
(10 nmol L)1), BAs (100 lmol L)1; Sigma-Aldrich, St. Louis, MO,
USA) or vehicle (0.1% ethanol) for 5 min. cAMP was measured by
chemiluminescent ELISA (Applied Biosystems Inc., Foster City,
CA, USA).
GpBAR1 antibody characterization by
immunofluorescence
HEK-GpBAR1-GFP or HEK-VC cells were fixed in 4% parafor-
maldehyde (0.1 M PBS, pH 7.4, 20 min, 4 C). Cells were washed
with PBS containing 0.1% saponin and 1% normal goat serum and
incubated with GpBAR1 antibody or GpBAR1 antibody pread-
sorbed with immunizing peptide (50 lmol L)1, overnight, 4 C)
(overnight, 4 C). Cells were washed and incubated with goat anti-
rabbit Rhodamine Red X (Jackson Immunoresearch, Westgrove,
PA, USA; 1 : 200, 2 h, room temperature). Cells were washed and
mounted.
GpBAR1 antibody characterization by Western
blotting
Total membranes were prepared from HEK-GpBAR1-GFP or HEK-
VC cells. Proteins (25 lg) were separated by SDS–PAGE (12%
acrylamide) and transferred to polyvinylidene difluoride mem-
branes (Immobilon-FL; Millipore, Billerica, MA, USA). Mem-
branes were blocked (Odyssey Blocking Buffer; LI-COR
Biosciences, Lincoln, NE, USA) and incubated with antibodies to
GpBAR1, preadsorbed GpBAR1 or GFP. Membranes were washed
and incubated with secondary antibodies conjugated to AlexaFlu-
or680 (Invitrogen) or IRDye800 (Rockland Immunochemicals
Inc., Gilbertsville, PA, USA; 1 : 10 000, 1 h, room temperature).
Immunoreactive bands were detected by using an Odyssey
infrared imaging system (LI-COR Biosciences, Lincoln, NE, USA).
Detection of GpBAR1 in the mouse
gastrointestinal tract by RT-PCR
Total RNA from mouse tissues was treated with DNase I
(Ambion, Austin, TX, USA), and reverse transcribed. G protein
coupled bile acid receptor 1 was amplified using primers for
mouse GpBAR1 (forward, 5¢-cactgcccttctctctgtcc-3¢, +537 to +556;
reverse, 5¢-agttcaggtccagttacgc-3¢, +985 to +966). To exclude
contamination by genomic DNA, control reactions omitted
reverse transcriptase. Products were separated by electrophoresis
on a 2% gel, detected with ethidium bromide, and sequenced.
GpBAR1 localization in gastrointestinal tissue
To prepare tissue sections, mouse tissues were fixed in 4%
paraformaldehyde (overnight, 4 C), cleared with dimethyl sulf-
oxide and PBS washes (3 · 10 min), and incubated in 30% sucrose
PBS (overnight, 4 C). Tissues were embedded in Optimal Cutting
Temperature compound (Tissue-Tek, Sakura Finetek, Torrance,
CA, USA) and sectioned (10–12 lm). Sections were incubated in
PBS containing 10% normal horse serum and 0.1% Triton X-100
(1 h, room temperature). Sections were then incubated with
primary antibodies (overnight, 4 C), washed, incubated with
donkey anti-rabbit, -chicken or -goat IgG conjugated to Rhoda-
mine Red X or FITC (Jackson; 1 : 200, 1 h, room temperature), and
mounted. To prepare whole mounts, intestine was placed in cold
PBS containing nicardipine (1 lmol L)1) to inhibit smooth muscle
contraction. The intestine was opened, fixed with 4% parafor-
maldehyde (overnight, 4 C), and whole mount dissections were
made of the longitudinal muscle-myenteric plexus and submu-
cosa-submucosal plexus.31 Tissue was then processed for indirect
immunofluorescence.
Confocal microscopy
Specimens were observed by using a Zeiss LSM510 META
confocal system (Carl Zeiss Inc., Thornwood, NY, USA). Images
were collected at 1024 · 1024 pixel resolution using Zeiss objec-
tives (Plan-Neofluar 40· NA 1.3; Fluar Plan Apochromat 63·, NA
1.4; Plan Apochromat 100·NA 1.4), with digital zooms of 0.7–1.3.
Intestinal motility
Full thickness segments (1 cm) of terminal ileum and proximal
colon were mounted in organ baths (3 mL) in physiological saline
solution (mmol L)1: 118 NaCl, 4.8 KCl, 2.5 NaHCO3, 1.0
NaH2PO4, 1.2 MgSO4, 11.1 D-Glucose, 2.5 CaCl2) under 1 g
tension (37 C, 5% CO2/95% O2). Longitudinal contractions were
recorded using isotonic transducers, and data were processed
using an analog-to-digital converter (MP100; Biopac Systems, Inc.,
Goleta, CA, USA), and analyzed using ACQKNOWLEDGE software
(v3.7.3; Biopac). Tissues were equilibrated for 30 min, and chal-
lenged with carbachol (1 lmol L)1) to assess viability. Tissues
were washed and challenged with DCA, taurodeoxycholic acid
(TDCA), UDCA (1–100 lmol L)1) or vehicle (0.1% ethanol or
distilled H2O). The mean amplitude of the basal tension and the
frequency of phasic contractions were determined 5 min before
and after challenge. In some experiments, tissues were preincu-
bated with atropine (1 lmol L)1, 10 min), hexamethonium
(10 lmol L)1, 10 min), N-nitro-L-arginine methyl ester (L-NAME,
300 lmol L)1, 30 min) or with tetrodotoxin (1 lmol L)1, 5 min)
(all from Sigma-Aldrich) prior to challenge with BAs.
Gastric emptying and small intestinal transit
Mice were fasted overnight with free access to water. Phenol red
(0.07% in 0.9% NaCl) alone (control) or containing 0.03 M DCA
or UDCA was administered by gavage (0.25 mL). After 30 min,
mice were killed, the stomach and small intestine were removed,
and the small intestine was divided into three equal segments.
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Tissues were homogenized with 0.5 mL of 0.1 N NaOH and
5.5 mL of H2O, and centrifuged. Supernatant (1.5 mL) was mixed
with 0.15 mL of trichloroacetic acid (30% w/v) to precipitate
proteins, and centrifuged. Supernatants (1 mL) were mixed with
NaOH (1 mL) and absorbance was measured at 570 nm and
compared to a standard curve. Gastric emptying was determined
as the proportion of administered phenol red remaining in the
stomach after 30 min, using the formula: % gastric empty-
ing = [(administered phenol red)gastric phenol red)/administered
phenol red] · 100. Small intestinal transit was evaluated as
geometric center of the distribution of the marker according to
the follow equation: geometric center = [S(phenol red in each
segment) · (segment number)]/administered phenol red.
Statistical data analysis
Data are presented as mean ± SEM and were analyzed using one-
way ANOVA with Newman-Keuls or Dunnetts multiple compar-
ison tests. A value of P < 0.05 was considered significant.
RESULTS
GpBAR1 is a functional receptor when expressed
in HEK cells
To verify that the cloned GpBAR1 receptor was
functional, we measured cAMP generation in response
to BAs known to activate GpBAR1.32 The primary BAs,
CDCA and CA, and the secondary BAs, TLCA, DCA
and LCA, (100 lmol L)1) stimulated cAMP generation
in HEK-GpBAR1-GFP cells (Fig. 1A). The potent
GpBAR1 agonists TLCA and DCA had the largest
effects, whereas UDCA, which activates GpBAR1 with
low affinity, was less active. The effects of TLCA, LCA
and DCA were concentration-dependent (10 nmol L)1–
100 lmol L)1, not shown). Bile acids did not stimulate
A B
C
Figure 1 G protein coupled bile acid receptor 1 (GpBAR1) antibody characterization. (A) Bile acid (BA)-stimulated cAMP generation. Human
embryonic kidney – G protein coupled bile acid receptor 1 – green fluorescent protein (HEK-GpBAR1-GFP) and HEK-VC cells were incubated with
vehicle (0.1% ethanol, EtOH), forskolin (10 nmol L)1) or BAs (100 lmol L)1) for 5 min. cAMP generation is expressed in pmol per well (n = 6).
(B) Localization of GpBAR1-IR by immunofluorescence. In HEK-GpBAR1-GFP cells, green fluorescent protein (GFP) and GpBAR1-IR colocalized at
the plasma membrane and in vesicles (upper row). Preadsorption (+peptide) abolished signal for GpBAR1-IR but not GFP (middle row). Neither GFP
nor GpBAR1-IR was detected in HEK-VC cells (bottom row). Scale bar = 10 lm. (C) Detection of GpBAR1-IR by Western blotting. Membranes from
HEK-GpBAR1-GFP or HEK-VC cells were separated by SDS–PAGE. The same blot was probed with antibodies to GFP (left) or GpBAR1 (middle) (right
lanes) or preadsorbed antibody to GpBAR1 (left lanes, +peptide). Merged images are in right panel. In membranes from HEK-GpBAR1-GFP cells,
antibodies to GFP and GpBAR1 detected proteins of 60–70 KDa, corresponding to the GpBAR1-GFP fusion protein (merged). In membranes from
HEK-VC cells, GFP-IR was undetectable and GpBAR1-IR was markedly diminished. Preadsorpion of GpBAR1 antibody did not affect GFP-IR but
suppressed GpBAR1-IR.
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cAMP generation in HEK-VC cells, and vehicle (0.1%
ethanol) was without effect. Thus, HEK-GpBAR1-GFP
cells express a functional BA receptor. These cells were
used to characterize the GpBAR1 antibody.
Specificity of the GpBAR1 antibody
We evaluated specificity of the GpBAR1 antibody by
immunofluorescence and Western blotting. In HEK-
GpBAR1-GFP cells, the GFP signal completely colo-
calized with GpBAR1-IR at the plasma membrane and
in vesicles (Fig. 1B). Preadsorption of the GpBAR1
antibody with the immunizing peptide abolished
GpBAR1-IR, whereas the GFP signal was unaffected.
GpBAR1-IR and GFP were not detected in HEK-VC
cells. In membranes prepared from HEK-GpBAR1-GFP
cells, the GFP and the GpBAR1 antibodies detected
proteins with apparent molecular masses of
65–70 kDa (Fig. 1C). The predicted molecular mass
of the GpBAR1-GFP fusion protein is 65 kDa
(GpBAR1 35 kDa, GFP 30 kDa). There are also
two sites for potential N-linked glycosylation, which
may account for the larger forms. Smaller proteins
detected by GFP and GpBAR1 antibodies may repre-
sent degradation products. Preadsorption with immu-
nizing peptide had no effect on GFP-IR signals but
markedly reduced signals for GpBAR1-IR, with the
exception of an unidentified protein at 80 kDa. In
HEK-VC cells, there were no detectable signals for
GFP-IR, and GpBAR1-IR signals were markedly dimin-
ished. Thus, the GpBAR1 antibody specifically inter-
acts with human GpBAR1.
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Figure 2 Localization of G protein coupled bile acid receptor 1-immunoreactivity (GpBAR1-IR) in sections of mouse stomach and small and large
intestine. (A) Representative examples of GpBAR1-IR in the wall of the gastric corpus (a, b, c) and antrum (d). GpBAR1-IR was expressed in the
myenteric plexus (MP). CM, circular muscle; LM, longitudinal muscle. Preadsorption of the GpBAR1 antibody with immunizing peptide abolished
GpBAR1-IR (C). (B) Representative examples of GpBAR1-IR in the wall of the duodenum (a), ileum (b), cecum (c) and colon (d) are shown. GpBAR1-IR
was expressed in the myenteric plexus (MP) and submucosal plexus (SMP) of the small and large intestine. GpBAR1-IR was more highly expressed in
the mucosa, muscularis externa (CM, circular muscle; LM, longitudinal muscle), of the small intestine compared to the large intestine. Preadsorption
of the GpBAR1 antibody with immunizing peptide abolished GpBAR1-IR.
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GpBAR1-IR and mRNA are widely expressed in
the gastrointestinal tract
We localized GpBAR1-IR in the mouse stomach and
intestine by indirect immunofluorescence. GpBAR1-IR
was most prominently detected in myenteric ganglia of
the gastric corpus and antrum (Fig. 2a). There was no
staining of the gastric mucosa or musculature. In the
small and large intestine, GpBAR1-IR was detected in
the enteric ganglia, muscularis externa and the mucosa
(Fig. 2b). The relative intensities of the GpBAR1-IR
signals consistently differed depending on the region.
In all regions of small and large intestine, GpBAR1-IR
was mainly localized to the enteric ganglia of the
myenteric and submucosal plexuses. In the small
intestine, GpBAR1-IR was also detected in the musc-
ularis externa and in the mucosa, where GpBAR1-IR
was present in enterocytes of the crypts and villi and in
unidentified cells in the lamina propria. In the cecum
and colon, GpBAR1-IR was detected at lower levels in
the muscle and mucosa, and was more prominently
detected in the enteric ganglia. In all segments, pread-
sorption of GpBAR1 antibody abolished staining
(Fig. 2), and no staining was observed when the
primary antibody was omitted (not shown). We exam-
ined expression of GpBAR1 mRNA in mouse gastro-
intestinal tissues by RT-PCR. A PCR product of the
predicted size (449 bp) was amplified from gallbladder,
liver, stomach, duodenum, ileum, cecum, and proxi-
mal and distal colon, but not from esophagus (Fig. 3).
Analysis of dissected tissues indicated expression of
GpBAR1 mRNA in the muscularis externa-myenteric
plexus and the submucosa-submucosal plexus of the
small and large intestine. Thus, GpBAR1 is widely
expressed throughout the gastrointestinal tract, partic-
ularly in enteric ganglia.
GpBAR1 is prominently expressed by inhibitory
motor neurons
To identify cell types expressing GpBAR1, we simul-
taneously localized GpBAR1 and PGP9.5 (pan-neuronal
marker), nitric oxide synthase (NOS, identifies inhib-
itory motor neurons and descending interneurons),
neurofilament M (NFM, identifies intrinsic primary
afferent neurons), choline acetyltransferase (ChAT,
identifies excitatory cholinergic neurons), or glial
fibrillary acidic protein (GFAP, identifies enteric
glia).33 We restricted this analysis to the intestine,
where GpBAR1-IR was more highly expressed than in
the stomach and where chemical coding of enteric
neurons is well established. Since GpBAR1-IR was
more prominent in the myenteric than the submucosal
plexus, quantification of neurons coexpressing marker
proteins was restricted to the myenteric plexus
(Table 2).
Myenteric plexus Within myenteric ganglia of the
small and large intestine, all cells expressing GpBAR1-
IR coexpressed PGP9.5, and between 43% (ileum) and
52% (proximal colon) of PGP9.5-positive neurons
coexpressed GpBAR1-IR (Fig. 4). Between 35%
(duodenum) and 59% (distal colon) of neurons
expressing GpBAR1-IR coexpressed NOS, and most
A
B
C
Figure 3 Amplification of G protein coupled bile acid receptor 1
(GpBAR1) mRNA in gastrointestinal tissues. A 449 bp product corre-
sponding to GpBAR1 was amplified and identified by sequence anal-
ysis. (A) GpBAR1 was amplified from gall bladder, liver and cecum,
with low levels in stomach and no detectable product in esophagus
(Esoph.). (B, C) GpBAR1 was highly expressed in dissected muscularis
externa-myenteric plexus (ME-MP) and expressed at lower levels in
dissected submucosa-submucosal plexus (SM-SMP) of duodenum
(Duod.), ileum, proximal colon (Prox. Co.) and distal colon (Dist. Co.).
No products were detected without reverse transcriptase (RT).
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NOS-positive neurons coexpressed GpBAR1-IR (84%
duodenum, 90% distal colon) (Fig. 5). A variable pro-
portion of GpBAR1-IR-positive neurons coexpressed
NFM (23% duodenum, 57% distal colon, not shown)
and ChAT (68% ileum, 28% distal colon, not shown).
This variability may reflect differences in the propor-
tion of different classes of neurons in these tissues. The
colocalization of GpBAR1-IR and GFAP in glial cells
was too infrequent to quantify, although colocalization
was more apparent in the large intestine than the small
intestine (Figure S1). Thus, GpBAR1-IR is almost
exclusively expressed in neurons rather than glial cells
of the myenteric plexus, where it is present in
approximately half of all neurons. Nearly all NOS-
positive neurons express GpBAR1-IR and a major pro-
portion of GpBAR1-IR neurons express NOS and are
inhibitory motor neurons or descending interneurons.
Submucosal plexus Nearly all submucosal neurons
expressing PGP9.5 coexpressed GpBAR1-IR in the
small and large intestine (Fig. 6A). Approximately
half of these GpBAR1-positive neurons coexpressed
ChAT-IR (Fig. 6B). Although these neurons were not
further characterized, the detection of GpBAR1 in
submucosal neurons suggests a role for this receptor in
regulation of mucosal secretion.
In whole mounts of the myenteric and submucosal
plexuses, preadsorption of GpBAR1 antibody abolished
staining (Fig. 4).
GpBAR1 activation inhibits intestinal
contractility
The localization of GpBAR1-IR in myenteric neurons
suggests that this receptor may mediate effects of BAs
on intestinal motility. Therefore, we examined the
effects of BAs on contractility of longitudinal muscle of
the small and large intestine. The potent GpBAR1
agonist DCA,32 caused a concentration-dependent
(1–100 lmol L)1) inhibition of spontaneous, phasic
contractions of ileum (not shown) and proximal colon
(Fig. 7A,B). The degree of inhibition was far greater in
the proximal colon (Fig. 7C) than the ileum (Fig. 7D).
The low affinity GpBAR1 agonist UDCA
(100 lmol L)1),32 which retains the detergent proper-
ties of DCA, had a minor effect compared to DCA
(Fig. 7A,C,D). The effects of the potent GpBAR1
agonist TDCA were examined in the ileum. TDCA
(100 lmol L)1) did not significantly alter the amplitude
or frequency of spontaneous contractions relative to
pretreatment values (Fig 7D). Tetrodotoxin
(1 lmol L)1, 5 min) and L-NAME (300 lmol L)1,
30 min) abolished DCA-induced inhibition of motility
in the ileum and proximal colon (Fig. 7A,C,D). The
inhibitory effects of DCA on the proximal colon were
significantly reduced by hexamethonium (10 lmol L)1,
10 min), but not by atropine (1 lmol L)1, 10 min)
(Fig. 7C). Thus DCA, a potent GpBAR1 agonist, inhib-
its intestinal motility by a neurogenic, cholinergic and
nitrergic mechanism that is consistent with the
prominent localization of GpBAR1 to inhibitory motor
neurons and ChAT-IR cholinergic neurons.
GpBAR1 activation delays gastric emptying and
small intestinal transit
To determine whether luminally administered BAs
affect gastrointestinal transit in mice, we adminis-
tered DCA, UDCA or vehicle (control) by gavage. We
assessed gastric emptying and small intestinal transit
Table 2 Quantification of neurons in myen-
teric plexusRegion PGP9.5 (%) NOS (%) NFM (%) ChAT (%)
Duodenum A126/126 (100) 52/147 (35) 3/52 (6) 60/157 (38)
B126/295 (43) 52/62 (84) 3/13 (23) 60/90 (67)
Ileum 177/177 (100) 97/213 (46) 10/130 (8) 54/140 (39)
177/425 (42) 97/114 (85) 10/26 (38) 54/79 (68)
Cecum 102/102 (100) 158/265 (60) 24/103 (23) 35/85 (41
102/220 (46 158/177 (89) 24/49 (49 35/89 (39)
Proximal colon 175/175 (100) 106/216 (49) 13/110 (12) 30/77 (39)
175/335 (52) 106/123 (86) 13/54 (24) 30/74 (41)
Distal colon 113/113 (100) 140/255 (59) 21/128 (16) 32/133 (24)
113/242 (47) 140/156 (90) 21/37 (57) 32/113 (28)
ChAT, choline acetyltransferase; GpBAR1, G protein coupled bile acid receptor 1; NFM, neurofi-
lament M; NOS, nitric oxide synthase.
For each region, the upper numberA indicates the number of marker-positive neurons in the
GpBAR1-positive population (i.e. in duodenum, of 126 cells expressing GpBAR1, 126 expressed
PGP9.5), and the lower numberB indicates the number of GpBAR1-positive cells in the marker-
positive population (i.e. in duodenum, of 295 cells expressing PGP9.5, 126 expressed GpBAR1).
For all regions, n ‡ 3 mice.
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of phenol red. Compared to control mice treated with
vehicle, DCA significantly delayed gastric emptying
(Fig. 8A) and small intestinal transit (Fig. 8B,C). With-
in 30 min of phenol red administration to control
mice, gastric emptying was 54.3% and 14% of the
marker was in the distal third segment of the small
intestine (geometric center 2.7). In mice treated with
DCA, gastric emptying was decreased by approxi-
mately twofold, 81.4% of the marker was in the first
intestinal segment, 18.6% of the marker was in the
second segment, and marker was absent from the
third intestinal segment (geometric center 2.2).
UDCA did not affect gastric emptying or small
intestinal transit compared to control. Thus, luminal
administration of a BA that activates GpBAR1 inhib-
its gastric emptying and small intestinal transit in
mice.
DISCUSSION
We report the unexpected localization of GpBAR1-IR
in myenteric and submucosal neurons of the mouse
intestine. A large proportion of GpBAR1-expressing
neurons of the myenteric plexus coexpressed NOS and
is thus inhibitory motor neurons or descending inter-
neurons, and the majority of these neurons expressed
GpBAR1-IR. Consistent with this localization, a BA
that is a potent GpBAR1 agonist inhibited motility of
intestinal segments by a neurogenic, nitrergic mecha-
nism, and delayed gastric emptying and intestinal
A
B
C
D
Figure 4 Localization of GpBAR1-IR and
PGP9.5-IR in whole mounts of myenteric
plexus. GpBAR1-IR (left panels) was
detected in approximately half of all myen-
teric neurons expressing PGP9.5-IR (middle
panels) in the ileum (A), cecum (B) and distal
colon (C). Merged images (right panels)
demonstrate colocalization of GpBAR1-IR
and PGP9.5-IR (arrowheads). Although cells
expressing GpBAR1-IR almost always
expressed PGP9.5-IR, some PGP9.5-IR posi-
tive neurons did not express GpBAR1-IR
(arrowheads with asterisk). (D) Preadsorp-
tion of the GpBAR1 antibody with immu-
nizing peptide abolished GpBAR1-IR in the
ileum. Scale bars = 50 lm.
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transit. Our results reveal a novel function for BAs and
GpBAR1 in the enteric nervous system, and provide a
mechanistic explanation for the well-known actions of
BAs on intestinal motility.
We detected GpBAR1-IR and mRNA throughout the
gastrointestinal tract, with distinct regional differ-
ences. G protein coupled bile acid receptor 1 mRNA
was highly expressed in the mouse gall bladder, liver
and small and large intestine, including separated
muscularis externa-myenteric plexus and submucosa-
submucosal plexus. Lower levels were detected in the
stomach and GpBAR1 was undetectable in the esoph-
agus. These results agree with GpBAR1 mRNA expres-
sion in human tissues.13 We observed regional
differences in GpBAR1-IR in the small and large
intestine, with prominent localization in the mucosa
and muscularis externa of the small intestine but not
the colon. Although GpBAR1-IR was present in
enterocytes of the small intestine, it was also present
in unidentified cells in the lamina propria that may be
macrophages or monocytes.12 We did not detect
GpBAR1-IR in the colonic mucosa, which agrees with
its lack of expression in colonic epithelial cell lines.13
However, GpBAR1 mRNA is present in cell lines
derived from intestinal endocrine cells, where activa-
tion stimulates hormone release.13,19 It will be impor-
tant to determine whether GpBAR1 is present in
endocrine cells of the small and large intestine, where
activation could control the secretion of hormones that
regulate motility and gall bladder contraction.
The major unexpected finding of our study is the
prominent localization of GpBAR1 in enteric neurons.
A
B
C
D Figure 5 Localization of GpBAR1-IR and
NOS-IR in whole mounts of myenteric
plexus. Most (>80%) neurons expressing
GpBAR1-IR (left panels) also expressed NOS-
IR (middle panels) in the duodenum (A),
ileum (B), cecum (C) and proximal colon (D).
Merged images (right panels) demonstrate
colocalization of GpBAR1-IR and NOS-IR
(arrowhead). Neurons expressing only
GpBAR1-IR or NOS-IR are indicated
(arrowheads with asterisk). Scale
bars = 50 lm.
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GpBAR1-IR was present in approximately half of all
myenteric neurons of the intestine. Within the myen-
teric plexus, most NOS-positive inhibitory neurons
(>80%) expressed GpBAR1-IR, and a high proportion
of GpBAR1-positive neurons coexpressed NOS, espe-
cially in the large intestine (49–60%). Detection of
GpBAR1-IR in NOS-positive inhibitory neurons of the
myenteric plexus suggests that these neurons mediate
the inhibitory actions of BAs on intestinal motility.
Supporting this suggestion, DCA, a potent agonist of
GpBAR1, strongly inhibited spontaneous contractions
of longitudinal muscle from the proximal colon,
whereas UDCA, a weak agonist, had little effect.
Although DCA inhibited contractions of the proximal
colon and the ileum, the effect was far more marked in
the colon. This difference is unlikely to reflect the
minor differences in the proportion of GpBAR1-IR
neurons coexpressing inhibitory or excitatory trans-
mitters between the proximal colon and the ileum. A
more likely explanation is the presence of GpBAR1-IR
in muscle cells of the ileum but not the colon, allowing
BAs to directly affect ileal muscle. In both tissues,
tetrodotoxin and L-NAME abolished the effects of
DCA. Bile acids also inhibit contractions of isolated
rabbit and guinea pig ileum.29,30 Our results are
consistent with the novel hypothesis that BAs activate
GpBAR1 on inhibitory motor neurons to release NO,
which inhibits spontaneous contractions of the
A
B
Figure 6 Localization of GpBAR1-IR,
PGP9.5-IR and ChAT-IR in whole mounts of
submucosal plexus. Localization of
GpBAR1-IR (left panels) and PGP9.5-IR
(middle panels) (A) or ChAT-IR (middle
panels) (B) in duodenum and distal colon.
Merged images (right panels) indicate
invariable colocalization of GpBAR1-IR and
PGP9.5-IR, and frequent colocalization of
GpBAR1-IR and ChAT-IR (arrowheads).
Some neurons expressing GpBAR1-IR did
not express ChAT-IR (arrowheads with
asterisk). Scale bars = 20 lm.
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intestine. This may represent a physiologically impor-
tant mechanism, since luminal administration of DCA
also inhibited gastric emptying and delayed intestinal
transit in intact mice. The source of NO produced
cannot be directly determined using our current
methodology, and it may originate from non-neuronal
cells.34 Although BAs can activate muscarinic recep-
tors,35 our data demonstrating that DCA-evoked inhib-
itory effects on contractile activity were unaffected by
atropine indicates that muscarinic receptors are not
involved in these responses. Bile acids may also act on
the mucosa to release factors that control motility. The
possibility that BAs mediate their effects through a
GpBAR1-independent mechanism can only be directly
examined once GpBAR1-specific antagonists and
GpBAR1-deficient mice become readily available.
Our findings may explain the well-known effects of
luminal BAs on intestinal motility. Bile acid infusion
A
B
D
C
Figure 7 Effects of bile acids on spontaneous contractile activity of longitudinal muscle of the proximal colon and ileum. (A) Representative
recordings from proximal colon. Deoxycholic acid (DCA, 100 lmol L)1) immediately inhibited spontaneous phasic contractions, but did not alter
basal tone. Ursodeoxycholic acid (100 lmol L)1) did not reduce the frequency of spontaneous contractions. Tetrodotoxin (TTX) and L-NAME abol-
ished the effects of DCA. (B–D) Effects of treatments on frequency of contraction, in which the frequency prior to stimulation is normalized to 1. (B)
Effects of graded concentrations on DCA in proximal colon. (C, D) Tetrodotoxin and L-NAME abolished the effects of DCA in the proximal colon (C)
and ileum (D). The effects of DCA (100 lmol L)1) on the proximal colon were significantly reduced by hexamethonium, but not by atropine (C).
TDCA (100 lmol L)1) did not have any effect on spontaneous activity of the ileum relative to vehicle control (D). *P < 0.05, **P < 0.01, ***P < 0.001
(n ‡ 6).
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into the human jejunum or ileum inhibits transit,
suggesting the existence of intestinal BA receptors.26,27
Thus, BAs may contribute to the ileal brake, by which
BAs and lipids slow transit to permit complete diges-
tion and absorption.27,36 Our observations that
GpBAR1-IR is expressed by inhibitory motor neurons,
and that a GpBAR1 agonist inhibits contractions by a
neurogenic mechanism and delays transit, suggest that
GpBAR1 mediates the ileal brake. Studies of GpBAR1-
deficient mice are required to further evaluate this
possibility. The mechanism by which luminal BAs
activate neuronal GpBAR1 also remains to be deter-
mined. Luminal BAs could be transported across the
epithelium through specific BA transporters to activate
GpBAR1 on enteric nerve fibers or smooth muscle
cells,37 through a similar mechanism to that through
which glucose affects myenteric neurons.38 The more
hydrophobic BAs, DCA and CDCA can more readily
traverse the apical and basolateral plasma membrane
bilayers,39 thereby, theoretically crossing the epithe-
lium to reach submucosal or myenteric neurons. The
inability of TDCA to inhibit contractile activity of the
isolated ileum suggests that this hydrophilic BA does
not effectively access target neurons within the small
intestine. Luminal BAs may also affect the release of
hormones from entero-endocrine cells, since hormonal
mechanisms may also account for the BA-induced ileal
brake.29 Alternatively, BAs from the circulation may
activate the receptor on enteric neurons or other cell
types. GpBAR1-IR was colocalized with NFM-IR,
which has been characterized as a marker of intrinsic
primary afferent neurons (IPANs) in the mouse small
intestine.33 IPANs innervate the mucosa and other
neurons within the enteric circuitry,40 thus it is
possible that BAs mediate their effects through specific
activation of these neurons.
We detected GpBAR1-IR in intestinal submucosal
neurons, many of which contain ChAT and are
cholinergic secretomotor neurons or intrinsic primary
afferent neurons.33 It remains to be determined if non-
cholinergic secretomotor neurons containing vasoac-
tive intestinal peptide also express GpBAR1. Bile acids
stimulate secretion of fluid and mucus by a neuronal,
cholinergic mechanism,20–22 which may also depend
on NO generation.41 Our localization of GpBAR1-IR to
cholinergic submucosal neurons raises the possibility
that GpBAR1 mediates these effects of BAs on intes-
tinal secretion. Thus, GpBAR1-expressing secretomo-
tor neurons might function as chemo-sensors,
stimulating secretory reflexes as a defensive mecha-
nism to eliminate BAs and other noxious agents.
However, BAs may directly activate GpBAR1 or other
BA receptors on enterocytes to regulate fluid and
electrolyte secretion. Activation of GpBAR1 in the gall
bladder epithelium stimulates the cystic fibrosis trans-
membrane conductor regulator chloride channel to
promote chloride secretion.14 Additional studies are
required to define the role of GpBAR1 in BA-induced
secretion in the intestine.
In conclusion, we have described the unique local-
ization of the BA receptor GpBAR1 in the enteric
nervous system, where the receptor is suitably located
to mediate the effects of BAs on intestinal motility and
A
B
C
Figure 8 Effects of bile acids on gastric emptying and small intestinal
transit. Phenol red and deoxycholic acid (DCA), UDCA or vehicle
(control) were administered by gavage. After 30 min, the proportion of
the administered phenol red was determined in the stomach and in
three equal segments of small intestine. Gastric emptying (A), transit
of the marker in the intestinal segments (B) and the geometric center of
the marker in the small intestine (C) were determined. Compared to
control, DCA but not UDCA inhibited gastric emptying and caused
retention of the marker in the proximal segments of the intestine,
reducing the geometric mean of the marker distribution. *P < 0.05
(n ‡ 6).
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secretion. This report adds to the emerging role of
GpBAR1 in control of energy expenditure, weight gain,
blood flow, BA homeostasis and immune responses.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article:
Figure S1. Localization of G protein coupled bile acid receptor 1-immunoreactivity (GpBAR1-IR) and glial
fibrillary acidic protein-immunoreactivity (GFAP-IR) in whole mounts of myenteric plexus. GpBAR1-IR (left panels)
was rarely detected in enteric glial cells expressing GFAP (middle panels) in the myenteric plexus of the duodenum
(A), ileum (B), proximal colon (C), and distal colon (D). Merged images (right panels) indicate occasional instances of
colocalization in the large intestine (arrowheads), although most glial cells did not express GpBAR1-IR (arrowheads
with asterisk). Scale bars = 50 lm.
Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting materials
supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for
the article.
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